evidence table
Protein Timing Muscle Randomized Trial Evidence Table
Structured evidence table for Protein Timing Muscle Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Protein Timing Muscle Randomized Trial | Blood glucose level, glycated hemoglobin level, body weight, and fat mass decreased with green tea intervention, while muscle mass increased across all groups (all p Trial Registration: University Hospital Medical Information Network (UMIN): UMIN000058708. | 2 | Fuke S (2026) | Effects of Green Tea-Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8-Week Randomized Controlled Trial. |
| Protein Timing Muscle Randomized Trial | Catechins in green tea have been reported to enhance glucose tolerance and lipid metabolism. | 2 | Fuke S (2026) | Effects of Green Tea-Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8-Week Randomized Controlled Trial. |
| Protein Timing Muscle Randomized Trial | However, the influence of chronic intake timing on these outcomes in older adults has not been fully elucidated. | 2 | Fuke S (2026) | Effects of Green Tea-Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8-Week Randomized Controlled Trial. |
| Protein Timing Muscle Randomized Trial | With increased pharmacotherapy effectiveness, attention has shifted to the accompanying role of lifestyle interventions in optimizing health and wellbeing. | 4 | Peary A (2026) | To Reenvision and Redefine: Considering the Role of Lifestyle Interventions in the New Era of Second-Generation Obesity Management Medications. |
| Protein Timing Muscle Randomized Trial | Purpose of review This narrative review examines lifestyle considerations before, during, and after second-generation obesity management medication (OMM) treatment. | 4 | Peary A (2026) | To Reenvision and Redefine: Considering the Role of Lifestyle Interventions in the New Era of Second-Generation Obesity Management Medications. |
| Protein Timing Muscle Randomized Trial | Recent findings Second-generation OMMs, including semaglutide and tirzepatide, have demonstrated unprecedented weight losses of around 15-20% in recent trials, leading to their swift uptake in clinical care. | 4 | Peary A (2026) | To Reenvision and Redefine: Considering the Role of Lifestyle Interventions in the New Era of Second-Generation Obesity Management Medications. |
Source documents